Chemical composition, antioxidant and insecticidal activities of a new essential oil chemotype of Pinus nigra ssp. mauritanica (Pinaceae), northern Algeria

Essential oil (EO) of aerial parts (twigs and needles) of an Algerian-Moroccan endemic pine Pinus nigra Arn. ssp. mauritanica (Mair. & Pey.) (Pinaceae) collected in Northern Algeria were extracted by hydrodistillation (HD) and solid phase micro-extraction (SPME). The compounds were analysed using Gas Chromatography (GC) and GC-Mass Spectrometry (GC-MS). The mean oil yield was 0.23%, for twigs and 0.47% for needles. 83 and 91 compounds have been identified for needles and twigs respectively. Chemical divergences from all other studied Black pines worldwide were observed in needles where the major components identified by HD are β-caryophyllene (26.2%), germacrene D (17.2%), α-pinene (9.4%) unveiling a new chemotype. Significative qualitative and quantitative differences were observed in chemical composition, depending on both technics HD and SPME. Twigs showed a higher potential for the antioxidant activities DPPH, ABTS and β-carotene system than EO needles. In other hand, needles revealed a higher activity for all concentrations than twigs with significant differences (p < 0.05). For phosphomolybden tests, both EOs exhibited more significant antioxidant potential compared to the DPPH, ABTS, β-carotene and reducing power systems. Noticeable insecticidal effects with variable rate depending on used plant parts, concentration, duration and frequency of exposure were also observed

Pistacia lentiscus L. fruits showed promising antimutagenic and antigenotoxic activity using both in-vitro and in-vivo test systems

Pistacia lentiscus L. is one of the most popular medicinal plants attributed to its beneficial properties on human health. However, few toxicogenetic studies have been carried out. Therefore, the aim of this study was to examine the potential genotoxic/antigenotoxic and mutagenic/antimutagenic properties of oil, ethyl acetate and ethanolic extracts of P. lentiscus L. fruits using in vitro the Ames and Umu assays, as well as in vivo micronucleus (MN) test. Extracts did not exert any significant mutagenic/genotoxic effects but provided protection against standard mutagenic and genotoxic agents including 2 nitrofluorene (2-NF) at 2.5 and 5 µg/ml; sodium azide at 5 and 10 µg/ml; 3-methylcholanthrene (3-MC) at 25 and 50 μg/ml; cyclophosphamide (CP) at 50 and 100 μg/ml; 4-nitroquinoline 1-oxide (4-NQO) at 0.05 µg/ml and 2-amino-anthracene (AA) at 0.2 µg/ml. Further, cytotoxicity and selectivity were examined on human hepatocarcinoma (HepG2), and MCF-7 breast cancer cell lines as well as a human normal-like fibroblast cell line (TelCOFS02MA) using MTT assay. Among all extracts, PF1 (ethanolic) showed the most significant selectivity index (SI) (HepG2:11.98; MCF7:4.83), which led to further investigations using an animal model. Oral administration of PF1 (125–1000 mg/kg b.w.) significantly decreased the number of micronucleated cells in CP -initiated (50 mg/kg b.w.) mice, while the number of micronucleated reticulocytes (MNRET), micronucleated polychromatic erythrocytes (MNPCE) or mitotic index (MI) were not markedly affected. Further, PF1 significantly enhanced catalase (CAT) and superoxide dismutase (SOD) activities in the livers and kidneys of these animals. The obtained results indicated the beneficial properties of P. lentiscus L. fruits for use in therapy against harmful effects of genotoxic and mutagenic agents. However, while promising it should be noted that the obtained results are preliminary and need to be confirmed prior to therapeutic use